Osteopontin deletion drives hematopoietic stem cell mobilization to the liver and increases hepatic iron contributing to alcoholic liver disease.
Osteopontin deletion drives hematopoietic stem cell mobilization to the liver and increases hepatic iron contributing to alcoholic liver disease.
复制标题
骨桥蛋白缺失将造血干细胞动员驱动向肝脏动员,并增加对酒精性肝病的肝铁。
DOI:
10.1002/hep4.1116
复制
发表时间:
2018-01
影响因子:
5.1
通讯作者:
Nieto N
中科院分区:
文献类型:
--
作者:
Magdaleno F;Ge X;Fey H;Lu Y;Gaskell H;Blajszczak CC;Aloman C;Fiel MI;Nieto N
The aim of this study was to investigate the role of osteopontin (OPN) in hematopoietic stem cell (HPSC) mobilization to the liver and its contribution to alcoholic liver disease (ALD). We analyzed young (14‐16 weeks) and old (>1.5 years) wild‐type (WT) littermates and global Opn knockout (Opn−/−) mice for HPSC mobilization to the liver. In addition, WT and Opn−/− mice were chronically fed the Lieber–DeCarli diet for 7 weeks. Bone marrow (BM), blood, spleen, and liver were analyzed by flow cytometry for HPSC progenitors and polymorphonuclear neutrophils (PMNs). Chemokines, growth factors, and cytokines were measured in serum and liver. Prussian blue staining for iron deposits and naphthol AS‐D chloroacetate esterase staining for PMNs were performed on liver sections. Hematopoietic progenitors were lower in liver and BM of young compared to old Opn−/− mice. Granulocyte colony‐stimulating factor and macrophage colony‐stimulating factor were increased in Opn−/− mice, suggesting potential migration of HPSCs from the BM to the liver. Furthermore, ethanol‐fed Opn−/− mice showed significant hepatic PMN infiltration and hemosiderin compared to WT mice. As a result, ethanol feeding caused greater liver injury in Opn−/− compared to WT mice. Conclusion: Opn deletion promotes HPSC mobilization, PMN infiltration, and iron deposits in the liver and thereby enhances the severity of ALD. The age‐associated contribution of OPN to HPSC mobilization to the liver, the prevalence of PMNs, and accumulation of hepatic iron, which potentiates oxidant stress, reveal novel signaling mechanisms that could be targeted for therapeutic benefit in patients with ALD. (Hepatology Communications 2018;2:84–98)
登录
查看更多内容
影响因子:
13.5
作者:
Ge, Xiaodong;Leung, Tung-Ming;Arriazu, Elena;Lu, Yongke;Urtasun, Raquel;Christensen, Brian;Fiel, Maria Isabel;Mochida, Satoshi;Sorensen, Esben S.;Nieto, Natalia
通讯作者:
Nieto, Natalia
DOI:
10.1152/ajpgi.00014.2013
发表时间:
2013-05-01
影响因子:
4.5
作者:
Ge, Xiaodong;Lu, Yongke;Nieto, Natalia
通讯作者:
Nieto, Natalia
影响因子:
64.5
作者:
Mantel CR;O'Leary HA;Chitteti BR;Huang X;Cooper S;Hangoc G;Brustovetsky N;Srour EF;Lee MR;Messina-Graham S;Haas DM;Falah N;Kapur R;Pelus LM;Bardeesy N;Fitamant J;Ivan M;Kim KS;Broxmeyer HE
通讯作者:
Broxmeyer HE
影响因子:
24.5
作者:
Arriazu E;Ge X;Leung TM;Magdaleno F;Lopategi A;Lu Y;Kitamura N;Urtasun R;Theise N;Antoine DJ;Nieto N
通讯作者:
Nieto N
影响因子:
20.3
作者:
Boyerinas, Benjamin;Zafrir, Maya;Sipkins, Dorothy A.
通讯作者:
Sipkins, Dorothy A.